Pages
- About us
- Access to innovative medicines
- African journalists we respect
- Cookie Policy
- Customers
- Expertise
- Flexible Pricing Plan
- News
- Our World
- Our world
- Our world
- Partners
- Privacy Policy (GDPR)
- Sitemap
- St Tudors – Press Kit
- Stop the HAZREM permit – Press Kit
- Tell the Truth
- Terms of use
- Want to write for us? Got a story for us?
- Ways to contact Hyderus
- What we do
Posts
- The Hyderus Chronicles: Welcome to the Hyderus blog!
- Lessons from the candy store and the playground: how to defend government spending in hard times
- How come people in international development have not noticed the age of austerity?
- A Development Dilemma
- Let us have an agency pitch
- The way out of the maze for the pharmaceutical industry
- Bleak outlook for development assistance in 2012
- Pharmas intimacy problem with social media
- The Hyderus Chronicles: Take a quick office tour and meet our team!
- The Hyderus Chronicles: A typical day at the office in Cwmfelinfach
- Welsh Dimension 1
- The Hyderus Chronicles: The Welsh Dimension (II)
- The Hyderus Chronicles: The Welsh Dimension (III)
- The Hyderus Chronicles: St. Davids Day
- Is The Indian foreign policy too feeble to let it lead?
- Indian patients demand non-Ranbaxy medicines
- Innovation in health: New method uses clays to grow human bones
- Do cash transfer schemes work? Study by SEWA and UNICEF shows they do
- Is The Indian family planning policy coercive and abusive?
- Indian media pack turns on the worlds largest generic producer
- Award-winning spot on domestic violence
- Low-cost devices developed to reduce maternal mortality in India
- How not to handle a problem – look to HPV vaccines in Japan
- Brazils street protesters demand more spending on health
- When the powerful complain, editors usually roll over. Not on this vaccines story
- Are negotiations with the Taliban really just surrender talks?
- Mum, why did I have to get cervical cancer? “There was a vague sense of controversy about the vaccine”
- Is President Obama hypocritical on climate change?
- Multinational pharma goes on the offensive against Indian generics
- Are university frauds threatening the UK’s research standing?
- 11 billion people? No problem
- International thinktank calls for backroom deals between regulators, payers and pharma
- Vitamin supplements kill but get $27 billion a year in US consumer spending
- Orwell lives in UK gov’t: ODA progress is either “good”, “satisfactory” or … blank
- How South Africa is beating the AIDS epidemic
- What happens to the Gulf if the US doesn’t need its oil?
- Sue and get better: Brazil’s patchy health system explained
- British overseas development spending grows amidst cuts — as we predicted
- Big London meeting on the rôle of killing in partnerships for global health – blog
- Are we losing the fight for women’s health?
- How come the year’s best writing on cancer among poor women in India is from Forbes?
- Why being anxious will help you cope with life
- How Syria looks from Syria
- The WHO’s narrow vision of the private sector is alarming
- Brazil: was it Occupy or something longer lasting?
- Why do UK governments invest in global public health? Academic paper contains nuggets
- The background in Egypt: two good listens
- Anti-vaccine crazies back on the attack despite US HPV figures
- MERS: two surgeons call for checks on Hajj travellers, thoughtful writing on bugs jumping species
- Is India’s foreign policy feeble or wise?
- BRICS co-operation on health: where’s the beef?
- Nudges work better than penalties in US healthcare market
- Which country in Africa has the highest per capita GDP? (And 80% poverty)
- Gates Foundation boldly invests where no foundation has invested before – @gateshealth
- New treatments may cripple bacteria by stopping them from socialising
- $33 billion for supplements that kill but we expect others to pay for medicines
- Harvard: megatrends in healthcare (it’s all … dull)
- Lancet unfair about Russia’s new role as global donor, history with AIDS
- Which big country has very high child mortality and is upper middle income?
- Bye bye BRICS say investors
- Clinical trials often don’t answer real-life questions
- An insider’s view of what India and the USA really talked about in June
- Arrests of GSK execs in China maybe linked to push for lower prices
- Anti-vaccine fanatic gets network TV job
- Sources of best innovation? South Korea bottom; Russia and India doing well
- Researchers miss the point on drug price mess in middle income countries
- Brazil leads the world in digital news
- Where the poorest live and why there are many fewer of them
- Recession may be good for health; austerity kills
- If you think aid changes things, you should move to Afghanistan while you can
- “Snowden Republicans” confident they can change US foreign policy
- Slow progress in getting African tax revenues into health
- Cancer: over-diagnosed and over-treated
- Antibiotic resistance; “a risk as serious as terrorism”
- Electricity is the new health in Africa
- 80 percent of all antibiotics in the US used on farm animals
- Anaesthesia may double the risk of dementia
- NCDs and traffic deaths in Africa: fated to remain the poor cousins of infectious disease?
- Welsh companies do better in India than their English counterparts — look at Hyderus
- Reactions to the Bongo Bongo Land controversy #aid #development
- Indian delight over US decision on Samsung #patents – impact on #accesstomedicine
- Worst clinical trial abuse ever – at a US public university
- China in Africa isn’t good or bad. It’s a mix — says Chinese gov’t #ChinaAfrica
- As concerns over governance grow, Clinton Foundation shifts focus to women and children
- Liconomics: Chinese #greenenergy to grow at twice the rate of general economy
- When two economists decide to have a child #pregnancy
- #Rotavirus vaccine protects unimmunised adults
- How to avoid a stroke: dress shabbily
- Health decisions: time to confront our denial of the irrational
- Mobile phones are transforming healthcare in #Africa #africahealth #gavi
- Germany’s Greens are becoming a party of the rich #green #eco
- India’s patent system on medicine may be the new normal #accesstomedicine #india
- America’s bad value healthcare system #publichealth #healthecon
- Time to retire the IPCC? Nature seems to think so #climatechange
- Public-private partnerships watch out: audited results might be required #development #syngenta #csr
- Nodding syndrome a deadly mystery in East Africa #ntd #uganda
- Keeping ODA at home – some surprising candidates
- In #Africa, the rich thrive but the poor sink — new survey confirms
- India may start seizing #patent rights for #greenenergy
- India’s policy in #greenenergy and #cleantech #patents is “expropriation” says newspaper
- Where do Iran and the West have shared interests in #Syria? What can’t be discussed in polite conversation
- South Africa breaks ranks with Brazil, China and India on #climatechange
- Cervical cancer: large study shows #HPV vaccines have no serious side effects #hpvvaccine
- China’s first global #vaccine against a backdrop of massive #sciencefraud
- Imagine telemedicine #Acano
- What Marriott’s leaked crisis guide tells you
- Why even good market research is becoming less reliable
- European governments increasingly wobbly on #climatechange and #greenenergy
- Reasons #polio may not be eradicated by 2018: a journal trips over itself #GPEI
- Girls in Rwanda better protected than girls in the US @GAVISeth #HPV #HPVaccine
- Reputation in a time of social media dominance and recession
- Living in an age when images never disappear
- Don’t waste money on #AIDS counselling, test
- #Indonesia #universalhealth plan seems destined for failure – BBC documentary
- Global development policymakers live in a tiny bubble
- What’s missing from #climatechange talks on #globalwarming? Media
- Bill Gates “satisfied” with #polio eradication in Nigeria but wishes it were India #GPEI #endpolio
- #MRSA infections cripple US professional football team #antibiotic resistance
- The Carbon Crooks — how organised crime took over carbon trading #COP19 #climate change
- Which rich countries are best and worst in the way they treat poor countries?
- WHO blocked #Syria #polio campaign for weeks because of regional in-fighting says Spiegel
- Medicines are never used unless pharma promotes them, says UK’s top left-wing magazine #badpharma
- Being trendy matters more than making sense in @TheLancet #Palestine
- The Brits are destroying the moral code of American journalism
- Business travellers matter more than sick people say developing country governments
- “The new drug war”: The Economist predicts a long wait for access to medicines
- An uncomfortable truth: sanctions create dissatisfaction — look at #Gaza for example #Palestine
- Insurance increases use of emergency rooms says new randomised study
- Health communications does not change the way anti-vaccine crazies behave
- Are there too few doctors in the world or are they just work-shy and cosseted?
- Gŵyl Dewi Sant yn India (the Welsh take over in Delhi)
- The coming water wars and how bored the media are with climate change
- Work experience blog by Jessica Jones
- Brazil’s shortage of doctors becomes a hot political topic
- Hyderus featured in The Times for policy research in difficult countries
- Shock finding: very sick people die sooner; very healthy people stay quite healthy
- Cyhoeddusrwydd i Hyderus wrth ennill cytundeb Indiaidd/ Publicity for Hyderus as it wins Indian Contract
- More Publicity for Hyderus
- Britain’s medical press: a tabloid mentality or a tool in bargaining by doctors?
- Are both sides in the climate change debate being “dirty, nasty and destructive”?
- Burson Marsteller and David Axelrod linked to high visibility failures
- Do negative ads really work? Yes. Just not how you thought
- Who would you trust more, the Kansas City Star or the British Medical Journal? #BMJ
- What drives Hamas? Fanaticism? Probably it’s understanding opinion polls #Gaza #Palestine
- UK parliamentary report on R&D for neglected diseases focuses on …. medieval Venice
- Does bad qualitative research guide US policy?
- Award-winning spot on gender violence
- WHO gets interesting on IP
- Poll: Chinese want action on climate more than Europeans or Americans
- A few brave psychiatrists speak out for #benzodiazepines
- Hyderus causing a stink!
- International declarations and treaties don’t change things — Tweets do
- The failure of global health advocacy spelled out in numbers
- Hyderus making bigger waves!!
- The Addis deal that will “turbo charge development”
- The basics about spending on health around the world
- Five myths about access to medicines in emerging markets
- Hyderus making tidal waves in the world of pharmaceutical journalism!
- Mark’s five myths about emerging markets made simple!
- Hyderus – it’s all about Community!
- Access to advanced medicines and affordability: a look forward to 2016
- Policy dialogue in the Twitter age
- India’s new medicine taxes hit the poor and the sick
- Media training needs a radical rethink
- What India will really do about access to innovative medicines
- Patagonia/Argentina – what’s our connection?
- The pharma industry’s access Catch-22
- The dangerous unreliability of quantitative market research seen in Brexit
- Hype for UN’s report on access to medicines is confused and contradictory
- Donald Trump’s stance on anti-vaccination
- Failed trials for Alzheimer’s may mean a key theory is wrong
- Mosquito-borne illness in 2017
- Biosimilars and the trastuzumab controversy
- Trump to remove critical funds from the CDC?
- A few more months for a six figure sum, the ethics of cancer medications
- The Human Development Index, what makes a country great?
- Pharmaceutical research: the price of failure
- Development aid to poorest nations falling in favour of domestic spending on refugees
- Measles outbreaks in Europe: anti-vaccination movement to blame?
- Developing nations going against trend of tobacco decline
- HIV treatment, CRISPR/cas9 and the safety of gene editing
- Tedros Adhanom Ghebreyesus, new WHO director-general
- Flu vaccine efficacy, a genetic uphill battle
- Mexico City Policy: Putting the US at odds with the EU?
- Trump withdraws from the Paris Agreement – global reaction
- The “post-antibiotic apocalypse”
- Global Fund welcomes Peter Sands as new Executive Director
- FDA shelf lives driving up the cost of healthcare
- Vaccination laws in EU nations set to cause conflict?
- Amazon to join the pharmaceutical market?
- Ambitious goals for UK Pharma, does the budget match up?
- The continued fight against polio
- Drug resistant HIV and the potential to render current treatments inviable
- Immunotherapy: the future of Alzheimer’s research?
- Robotic takeover of healthcare on the horizon?
- Axovant fails while Pfizer leaves – the grim outlook of Alzheimer’s research
- New hope for Huntington’s disease?
- Brexit: A boon for Big Tobacco?
- Indian patent laws, no longer the pharmacy of the developing world?
- TB ‘miracle cures’ and the issue of high expectations
- Blood test to detect early stage cancer
- Hyderus participates in study on whether EU funding has helped people with poverty related diseases
- Brexit uncertainty, blocking both medicines and migrants?
- US malaria donations saving two million children?
- Climate Change Forcing Nursing Industry to Reassess Practice and Policies
- Anti-vaccination movement show the damage conspiracy theories can do
- New strains of TB threaten to bypass current diagnostics
- The global gag rule does not stop abortions. It does the opposite.
- Parkinson’s and the difficulty of treating neurological conditions
- Vaccine Hesitancy – One of the world’s top 10 global health threats
- Disease epidemiology in the world’s newest megacities
- Business continuity in the era of a global virus pandemic
- PandemiCast I: Public policy in a pandemic
- PandemiCast II: The effect on the media
- PandemiCast III: The search for a vaccine
- PandemiCast IV: How coronavirus affects other conditions
- PandemiCast V: An update on public policy
- PandemiCast VI: Sexual and reproductive health
- PandemiCast VII: The importance of healthcare communications
- PandemiCast VIII: Sexual and reproductive health (II)
- PandemiCast IX: Epidemiological models amidst COVID-19
- PandemiCast X: Public policy in a pandemic (3)
- PandemiCast X: Public policy (3)
- PandemiCast XI: International Day of the African Child
- PandemiCast XII: How coronavirus has hit businesses and what the situation looks like going forward
- PandemiCast XIII: How COVID has hit HIV
- PandemiCast XIV: Why we need to pay attention to telehealth and telemedicine
- Russia’s coronavirus vaccine: The controversy, explained
- PandemiCast XV: A look at COVID-19 in Africa (Trailer)
- PandemiCast XV, Part I: The view from Africa
- PandemiCast XV, Part II: The view from Africa
Archives
- September 2020 (2)
- August 2020 (2)
- July 2020 (2)
- June 2020 (4)
- May 2020 (9)
- March 2020 (1)
- August 2019 (1)
- July 2019 (1)
- June 2019 (3)
- May 2019 (2)
- June 2018 (1)
- May 2018 (1)
- April 2018 (2)
- March 2018 (4)
- February 2018 (4)
- January 2018 (4)
- December 2017 (1)
- November 2017 (2)
- October 2017 (1)
- September 2017 (2)
- August 2017 (1)
- June 2017 (1)
- May 2017 (4)
- April 2017 (3)
- March 2017 (2)
- February 2017 (2)
- September 2016 (1)
- June 2016 (2)
- May 2016 (1)
- March 2016 (1)
- February 2016 (3)
- January 2016 (1)
- August 2015 (3)
- July 2015 (7)
- June 2015 (2)
- May 2015 (1)
- March 2015 (1)
- November 2014 (1)
- October 2014 (1)
- August 2014 (2)
- July 2014 (1)
- June 2014 (2)
- May 2014 (1)
- April 2014 (5)
- March 2014 (5)
- January 2014 (3)
- December 2013 (3)
- November 2013 (12)
- October 2013 (13)
- September 2013 (10)
- August 2013 (12)
- July 2013 (32)
- June 2013 (29)
- February 2013 (1)
- October 2012 (1)
- September 2012 (2)
- August 2012 (2)
- July 2012 (1)
- January 2012 (1)
- March 2011 (2)
- November 2010 (1)
- June 2010 (1)
- May 2010 (2)
The Three Commitments
Why Consultants end up not telling the truth
The worst kind of market research interviewing technique ever
Why bright people can’t explain themselves
